Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Qilu pays $38M upfront for rights to Minghui's ADC
Qilu Pharmaceutical is paying 280 million Chinese yuan ($38 million) for a licensing and collaboration deal with Minghui Pharmaceutical.
Ben Adams
May 9, 2025 7:20am
GE HealthCare cuts guidance due to tariffs, after strong quarter
Apr 30, 2025 11:50am
Boston Scientific plans to make ground despite tariff headwinds
Apr 24, 2025 12:15pm
Large trial reveals link between lowered BP and dementia risk
Apr 24, 2025 11:33am
Intuitive posts strong 1Q earnings as tariffs squeeze margins
Apr 23, 2025 11:00am
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
Apr 18, 2025 7:40am
